FDA Import Refusal 823-0116964-3/1/1 — Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare Company

Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare Company — FEI 1719513

The FDA refused shipment 823-0116964-3/1/1 from Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare Company (United States) on Aug 18, 2006. The refused product falls under Drugs and Biologics — TETRACYCLINE HYDROCHLORIDE (TETRACYCLINES). Cited charge: 118 This firm has 5 or more other import refusals on record.